Spero Therapeutics (NASDAQ:SPRO – Get Rating) will post its quarterly earnings results after the market closes on Thursday, March 31st. Analysts expect Spero Therapeutics to post earnings of ($0.81) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link. Shares of Spero Therapeutics stock […]

Related Keywords

Ankit Mahadevia , Wells Fargo Company , Zacks Investment Research , Spero Therapeutics Company Profile Get Rating , Spero Therapeutics Inc , Aquilo Capital Management Llc , Citigroup Inc , Barclays Plc , Spero Therapeutics , Get Rating , Investment Research , Aquilo Capital Management , Therapeutics Company Profile , Nasdaq Spro , Aspro , Medical , Earnings ,